Using a cut-off concentration of 527.52, the investigators found that the ratio of IGFBP-3/PSA in BPH tissue was distributed with 96% sensitivity and 96% specificity compared to normal prostate. Here, IGFBP3 is linked to benign prostatic hyperplasia.